$CTGO
Contango ORE, Inc.

2018 Q2 Form 10-K Financial Statement

#000143774918016402 Filed on August 30, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2 2017
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.380M $770.0K $2.836M
YoY Change 79.22% 185.19% 132.45%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.380M $770.0K $2.836M
YoY Change 79.22% 185.19% 132.45%
Operating Profit
YoY Change
Interest Expense -$2.420M $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.810M -$770.0K -$2.836M
YoY Change 394.81% 185.19% 132.45%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.810M -$770.0K -$2.836M
YoY Change 394.81% 185.19% 132.45%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$621.5K -$157.1K -$615.5K
COMMON SHARES
Basic Shares Outstanding 4.904M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2017 Q2 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.81M $5.190M $5.192M
YoY Change 166.09% 315.2% 313.85%
Cash & Equivalents $13.81M $5.192M
Short-Term Investments
Other Short-Term Assets $160.0K $180.0K $175.8K
YoY Change -11.11% 200.0% 202.2%
Inventory
Prepaid Expenses $155.7K $175.8K
Receivables
Other Receivables
Total Short-Term Assets $13.97M $5.368M $5.368M
YoY Change 160.2% 308.91% 308.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $13.97M $5.368M $5.368M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $13.97M $5.368M $5.368M
YoY Change 160.2% 308.91% 308.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.19K $50.86K $50.86K
YoY Change -77.99% 143.88% 143.93%
Accrued Expenses $245.2K $86.56K $86.56K
YoY Change 183.28% -6.81% -6.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $256.4K $137.4K $137.4K
YoY Change 86.59% 20.82% 20.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $256.4K $137.4K $137.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $260.0K $140.0K $137.4K
YoY Change 85.71% 27.27% 20.82%
SHAREHOLDERS EQUITY
Retained Earnings -$41.30M -$35.11M
YoY Change 17.63% 8.79%
Common Stock $55.01M $40.55M
YoY Change 35.66% 21.14%
Preferred Stock
YoY Change
Treasury Stock (at cost) $207.4K
YoY Change
Treasury Stock Shares $0.00 $9.068K
Shareholders Equity $13.71M $5.230M $5.230M
YoY Change
Total Liabilities & Shareholders Equity $13.97M $5.368M $5.368M
YoY Change 160.2% 308.91% 308.91%

Cashflow Statement

Concept 2018 Q2 2017 Q2 2017
OPERATING ACTIVITIES
Net Income -$3.810M -$770.0K -$2.836M
YoY Change 394.81% 185.19% 132.45%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$250.0K -$420.0K -$1.143M
YoY Change -40.48% 366.67% 65.02%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$2.580M -$2.580M
YoY Change
Cash From Investing Activities -$2.580M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -40.00K 5.080M
YoY Change -100.0% 0.0%
NET CHANGE
Cash From Operating Activities -250.0K -420.0K -1.143M
Cash From Investing Activities -2.580M
Cash From Financing Activities 0.000 -40.00K 5.080M
Net Change In Cash -2.830M -460.0K 3.937M
YoY Change 515.22% 411.11% -668.51%
FREE CASH FLOW
Cash From Operating Activities -$250.0K -$420.0K -$1.143M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
5851376
CY2017Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
8747508
CY2018 ctgo Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Related To Tax Reform Amount
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceRelatedToTaxReformAmount
-4868970
CY2017 ctgo Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Related To Tax Reform Amount
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceRelatedToTaxReformAmount
CY2018Q2 ctgo Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2
CY2018Q2 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
35625
CY2017Q2 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
845999
CY2017 ctgo Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
5287500
CY2018 ctgo Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
2322491
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11192
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
50858
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
245212
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86561
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
54949370
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
40500239
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
207400
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1787558
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2468645
CY2018 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
642143
CY2018Q2 us-gaap Assets
Assets
13966476
CY2017Q2 us-gaap Assets
Assets
5367540
CY2018Q2 us-gaap Assets Current
AssetsCurrent
13966476
CY2017Q2 us-gaap Assets Current
AssetsCurrent
5367540
CY2018Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2017Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2018 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> Basis of Presentation</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 24pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America.</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; color: rgb(0, 0, 0); text-indent: 24pt; font-size: 10pt; background-color: rgb(255, 255, 255);"></div> <div style=" margin: 0pt; text-align: justify; color: rgb(0, 0, 0); text-indent: 24pt; font-size: 10pt; background-color: rgb(255, 255, 255);">These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. Since the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s primary business is now the investment in and management of the Joint Venture Company, it expects that its ongoing cash requirements will only be related to general and administration expenses. Given this, the Company believes that its current cash balances will be sufficient to meet its working capital requirements for the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months from the date of this report.</div></div></div>
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5191749
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254489
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13810805
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8619056
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3937260
CY2018Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
35625
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6153266
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4930231
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6153266
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4921163
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
61533
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
49303
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
3767586
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
2836453
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2018Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2017Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2454203
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3260495
CY2018Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
3122042
CY2017Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
2118225
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
523249
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
125855
CY2018Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11950870
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14252083
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.09
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2806
CY2018Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2017Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3767586
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2836453
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6188810
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2836453
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2580000
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2567757
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1178992
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
4868970
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1736580
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-992759
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-81455
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
30213
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-251074
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-41218
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-498648
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-175228
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
118985
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
23681
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-20120
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
117626
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
158776
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13966476
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5367540
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
256404
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
137419
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12200116
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5080100
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2580000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1001060
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1142840
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-6188810
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-2836453
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2421224
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
CY2018Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
11700000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
207400
CY2018 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2580000
CY2017 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
155671
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
175791
CY2018 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12200116
CY2017 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5287500
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41300831
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35112021
CY2010Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1600000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2468645
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1787558
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
35625
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.01
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
35625
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.01
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
10
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
10.99
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P73D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P73D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10519768
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1198916
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
5230121
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
13710072
CY2018 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
CY2018Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
9068
CY2018Q2 us-gaap Treasury Stock Value
TreasuryStockValue
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
207400
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Management Estimates.</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2300000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5675366
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4608177

Files In Submission

Name View Source Status
0001437749-18-016402-index-headers.html Edgar Link pending
0001437749-18-016402-index.html Edgar Link pending
0001437749-18-016402.txt Edgar Link pending
0001437749-18-016402-xbrl.zip Edgar Link pending
a2016phase1explorationprogra.jpg Edgar Link pending
a2017phaseiiimap.jpg Edgar Link pending
conta20180810_10k.htm Edgar Link pending
ctgo-20180630.xml Edgar Link completed
ctgo-20180630.xsd Edgar Link pending
ctgo-20180630_cal.xml Edgar Link unprocessable
ctgo-20180630_def.xml Edgar Link unprocessable
ctgo-20180630_lab.xml Edgar Link unprocessable
ctgo-20180630_pre.xml Edgar Link unprocessable
ex_121404.htm Edgar Link pending
ex_121405.htm Edgar Link pending
ex_121406.htm Edgar Link pending
ex_121407.htm Edgar Link pending
ex_121408.htm Edgar Link pending
ex_121410.htm Edgar Link pending
ex_121410img001.gif Edgar Link pending
ex_121410img002.gif Edgar Link pending
ex_123000.htm Edgar Link pending
ex_123007.htm Edgar Link pending
ex_123084.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gradexthicknessmainpeakandno.jpg Edgar Link pending
locationofassetsmap-new.jpg Edgar Link pending
phaseiiimap.jpg Edgar Link pending
phaseiimapwallholes.jpg Edgar Link pending
phaseimap.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tet18-chiefdannydrill_areasc.jpg Edgar Link pending
tet18-copperhilldrill_areasc.jpg Edgar Link pending
tetlinmap-phaseii2016program.jpg Edgar Link pending